Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Community pharmacy

Prescription analysis tool allows pharmacists to benchmark performance

A new prescription analysis system for community pharmacists in the UK has been launched by the Pharmaceutical Services Negotiating Committee (PSNC) and the National Pharmacy Association (NPA).

The system, called Check34, allows community pharmacy contractors to monitor and analyse trends and anomalies in prescription payments and track performance indicators. The online system also allows users to benchmark their performance against regional and national data, giving insights into business management and planning.

Check34 was developed as a business analysis tool and the NPA and PSNC say there are no plans to make the data available to anyone other than contractors. However, David Wright, professor of pharmacy practice at the University of East Anglia, notes that with the appropriate permissions and anonymisation, it is potentially an excellent resource for researchers who are interested in prescribing trends, patterns in community pharmacy service provision and changes in prescription workload.

“It should provide data that enable generalisations to be made regarding the provision of NHS nationally funded community pharmacy services and is of sufficient size to enable important differences in practice to be identified,” he says.

The idea of harnessing the Check34 database for research was also welcomed by Michael Twigg, research fellow in pharmacy practice at the University of East Anglia. “It will also be interesting to observe, in light of recent suggestions that pharmacists should be checking the exemption status of patients more closely, what impact the ‘switched prescriptions’ data have on how pharmacists approach this discussion both with patients and within the profession,” he says. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068398

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.